For the Inventor, By the Inventor

Enter assignee name

Rockville, MD, United States of America

Entremed, Inc.

USPTO Granted Patents = 28

% Expired Patents = 32.1

Forward Citations = 869

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Shawn J Green (10 out of 15 patents)

Anthony Treston (7 out of 14 patents)

Gregory E Agoston (7 out of 9 patents)

4. Jamshed H Shah (7 out of 16 patents)

5. John W Holaday (5 out of 14 patents)

6. Adonia E Papathanassiu (5 out of 12 patents)

7. John W Madsen (5 out of 10 patents)

8. Theresa Marie LaVallee (4 out of 7 patents)

9. Glenn M Swartz, Jr (3 out of 7 patents)

10. Victor S Pribluda (3 out of 4 patents)

11. Peter M Meserol (3 out of 25 patents)

12. Stacy Plum (2 out of 6 patents)

13. Carl R Alving (2 out of 34 patents)

14. Lita Suwandi (2 out of 2 patents)

15. Kim Lee Sim (2 out of 13 patents)

Core Competencies:

Anti-Angiogenic Agents

2-Methoxyestradiol

Estradiol Derivatives

Cellular Proliferation

Cancer Treatments

Angiogenesis Inhibition

Pharmaceutical Compositions

Immune System Stimulation

Flow Electroporation

Anti-Estrogenic Compounds

Nitric Oxide Generators

Vaccines Against Sterols

28 patents: Sort by Forward Citations

1. 8399440 - Disease modifying anti-arthritic activity of 2-methoxyestradiol (2013-03-19),

2. 8158612 - Methods of treating disease states using antiangiogenic agents (2012-04-17),

3. 7498322 - Antiangiogenic agents (2009-03-03),

4. 7371741 - Estradiol derivatives and pharmaceutical compositions using same (2008-05-13),

5. 7235540 - Methods of using 2-methoxyestradiol of high purity (2007-06-26),

6. 7135581 - Antiangiogenic agents (2006-11-14),

7. 7087592 - Compositions comprising purified 2-methoxyestradiol and methods of producing same (2006-08-08),

8. 6995278 - Antiangiogenic agents (2006-02-07),

9. 6946439 - Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments (2005-09-20),

10. 6805865 - Compositions and methods for treating cancer and hyperproliferative disorders (2004-10-19),

11. 6734163 - Compositions and methods for inhibiting cellular proliferation (2004-05-11),

12. 6723536 - Method of producing and purifying angiostatin (2004-04-20),

13. 6605622 - Use of anti-estrogenic compounds as anti-fungal agents (2003-08-12),

14. 6593291 - Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease (2003-07-15),

15. 6544947 - Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using cancer markers (2003-04-08),

Company Overview

Entremed, Inc. is a biotechnology company based in Rockville, Maryland, specializing in the development of innovative therapeutics for the treatment of cancer and other serious diseases. The company focuses on advancing its proprietary drug candidates through rigorous research and clinical development, leveraging its expertise in molecular biology and pharmacology. Entremed is committed to addressing unmet medical needs by exploring novel therapeutic approaches and enhancing patient outcomes through targeted therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

28 Patents

#26 in Rockville, MD

#154 in Maryland

#12,016 in US

#23,299 in the World

Rockville, MD, United States of America

Entremed, Inc.

Forward Citations = 869

42 inventors:

Shawn J Green (10 out of 15 patents)

Anthony Treston (7 out of 14 patents)

Gregory E Agoston (7 out of 9 patents)

4. Jamshed H Shah (7 out of 16 patents)

5. John W Holaday (5 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Entremed, Inc.. Retrieved from https://idiyas.com/company/entremed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…